Home › Compare › Tirzepatide vs Survodutide
Tirzepatide vs Survodutide
Tirzepatide and Survodutide are both metabolic / weight loss peptides, which is why they get recommended interchangeably — but they are different compounds with different origins. A mixed vial also keeps differently: about 56 days for Tirzepatide against 30 for Survodutide. The table below sets out the differences. We give no dosing guidance.
Side by side, in plain English — what each one is, where they overlap and where they genuinely differ.
TirzepatideMetabolic / Weight Loss
SurvodutideMetabolic / Weight LossAt a glance
| Tirzepatide | Survodutide | |
|---|---|---|
| Category | Metabolic / Weight Loss | Metabolic / Weight Loss |
| Typical route | SubQ | SubQ |
| Shelf life once mixed | ~56 days | ~30 days |
| Commonly reported effects | Aggressive fat loss Appetite reduction Insulin sensitivity | Fat loss Increased metabolic rate Appetite suppression |
| Reported considerations | Nausea Vomiting Diarrhea | Nausea GI distress |
The differences that actually matter
Both are classed as Metabolic / Weight Loss peptides, so they get compared constantly and are often researched for overlapping reasons.
Once reconstituted, Tirzepatide keeps noticeably longer than Survodutide (~56 days vs ~30 days), so vial waste is a real difference between the two.
Where they overlap: aggressive fat loss, appetite reduction.
Reported mainly for Tirzepatide: insulin sensitivity.
Reported mainly for Survodutide: increased metabolic rate.
What Tirzepatide is
Tirzepatide functions as a dual agonist of the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. By activating both these incretin receptors, it synergistically enhances glucose-dependent insulin secretion from pancreatic beta cells and suppresses glucagon secretion from alpha cells, particularly after meals. This dual action also contributes to a delay in gastric emptying, which helps to moderate postprandial glucose excursions and promotes a feeling of satiety. Its
What Survodutide is
Survodutide is a peptide designed to function as a dual agonist for both the glucagon-like peptide-1 (GLP-1) and glucagon receptors. By activating GLP-1 receptors, it is understood to reduce appetite, slow gastric emptying, and enhance glucose-dependent insulin secretion, contributing to improved blood sugar regulation and feelings of fullness. Concurrently, its action on glucagon receptors is intended to increase energy expenditure and stimulate lipolysis, which is the breakdown of stored fats. This combined agoni
How to compare them for yourself
Anecdotes online are noisy because nobody is measuring the same thing. The only comparison that means anything is your own: log each entry with a timestamp, keep the vial ledger honest so you know what you actually got through, pick two or three metrics before you start, and look at the trend after several weeks rather than day to day.
Peptide Wizard does that part for you — Tirzepatide and Survodutide are both in the built-in reference library with a 3D vial, and your history, vial ledger and cost per entry stay private on your device.
FAQ
What is the difference between Tirzepatide and Survodutide?
Both are classed as Metabolic / Weight Loss peptides, so they get compared constantly and are often researched for overlapping reasons.
Can you log Tirzepatide and Survodutide in the same period?
Plenty of people record more than one peptide at a time. Peptide Wizard keeps a separate vial ledger and entry history for each, so you can see exactly what overlapped and when — it does not recommend combinations or doses.
Which is better, Tirzepatide or Survodutide?
There isn't a universal answer — reported responses vary a lot between individuals, which is why your own log is more informative than anyone else's anecdote. Track one variable at a time and compare your own metrics over several weeks.
Is this medical advice?
No. This page is educational reference material only. It contains no dosing guidance. Speak to a qualified healthcare professional before making any decisions.
See all peptide comparisons →
Educational reference only. This page contains no dosing guidance and is not medical advice.